Athira Pharma (ATHA) Earnings Date, Estimates & Call Transcripts

$2.04
-0.05 (-2.39%)
(As of 04:00 PM ET)

Earnings Summary

Upcoming
Earnings Date
May. 9Estimated
Actual EPS
(Feb. 22)
-$0.71 Beat By $0.25
Consensus EPS
(Feb. 22)
-$0.96
Skip Charts & View Estimated and Actual Earnings Data

ATHA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ATHA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Athira Pharma Analyst EPS Estimates

Current Year EPS Consensus Estimate:($2.86) EPS
Next Year EPS Consensus Estimate: ($3.00) EPS

ATHA Earnings Date and Information

Athira Pharma last released its quarterly earnings data on February 22nd, 2024. The reported ($0.71) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.96) by $0.25. Athira Pharma has generated ($3.09) earnings per share over the last year (($3.09) diluted earnings per share). Earnings for Athira Pharma are expected to decrease in the coming year, from ($2.86) to ($3.00) per share. Athira Pharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off prior year's report dates.

Athira Pharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/9/2024
Estimated)
------- 
2/22/2024Q4 2023($0.96)($0.71)+$0.25($0.71)--
11/9/2023Q3 2023($0.87)($0.87)-($0.87)--
8/10/2023Q2 2023($0.81)($0.78)+$0.03($0.78)--
5/11/2023Q1 2023($0.66)($0.73)($0.07)($0.73)--
3/23/2023Q4 2022($0.70)($0.79)($0.09)($0.79)--
11/10/2022Q3 2022($0.67)($0.53)+$0.14($0.53)--
8/15/2022Q2 2022($0.66)($0.65)+$0.01($0.65)--
5/12/2022Q1 2022($0.63)($0.56)+$0.07($0.56)--    
3/24/2022Q4 2021($0.61)($0.37)+$0.24($0.37)--    
11/9/2021Q3 2021($0.50)($0.42)+$0.08($0.42)--
8/15/2021Q2 2021($0.35)($0.38)($0.03)($0.38)--
5/12/2021Q1 2021($0.30)($0.25)+$0.05($0.25)--

Athira Pharma Earnings - Frequently Asked Questions

When is Athira Pharma's earnings date?

Athira Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 9th, 2024 based off last year's report dates. Learn more on ATHA's earnings history.

Did Athira Pharma beat their earnings estimates last quarter?

In the previous quarter, Athira Pharma (NASDAQ:ATHA) reported ($0.71) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.96) by $0.25. Learn more on analysts' earnings estimate vs. ATHA's actual earnings.

How much profit does Athira Pharma generate each year?

Athira Pharma (NASDAQ:ATHA) has a recorded net income of -$117.67 million. ATHA has generated -$3.09 earnings per share over the last four quarters.

What is Athira Pharma's EPS forecast for next year?

Athira Pharma's earnings are expected to decrease from ($2.86) per share to ($3.00) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:ATHA) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners